Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 11;58(3):728-744.e9.
doi: 10.1016/j.immuni.2025.02.004. Epub 2025 Feb 28.

Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later

Affiliations

Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later

Abby Spangler et al. Immunity. .

Abstract

Pre-existing immunity impacts vaccine responses to influenza, but directly connecting influenza infections early in life with immune responses decades later is difficult. However, H2N2 stopped circulating in the human population in 1968, creating the opportunity to directly evaluate the impact of early H2N2 exposure on vaccine responses 50 years later. Here, we vaccinated individuals born before (H2 exposed) or after (H2 naive) 1968 with an H2 hemagglutinin (HA) DNA plasmid and/or a ferritin nanoparticle vaccine. H2-exposed individuals generated a rapid B cell recall response that was more potent, targeted more conserved epitopes, and differed phenotypically from the de novo response in H2-naive individuals. Furthermore, vaccinating with a DNA versus a protein nanoparticle vaccine altered the response in H2-naive but not H2-exposed individuals. This study establishes and describes the lifelong impact of influenza HA-specific memory B cells formed early in life on vaccine responses decades later.

Keywords: B cells; H2; atypical B cells; immunoglobulin repertoire; imprinting; influenza vaccine.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Barberis I, Myles P, Ault SK, Bragazzi NL, and Martini M (2016). History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines. J Prev Med Hyg 57, E115–E120. - PMC - PubMed
    1. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. (2018). Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300. 10.1016/S0140-6736(17)33293-2. - DOI - PMC - PubMed
    1. Ryu S, and Cowling BJ (2021). Human Influenza Epidemiology. Cold Spring Harb Perspect Med 11. 10.1101/cshperspect.a038356. - DOI - PMC - PubMed
    1. Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, and Rimmelzwaan GF (2011). Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 18, 469–476. 10.1128/CVI.00396-10. - DOI - PMC - PubMed
    1. Sauerbrei A, Schmidt-Ott R, Hoyer H, and Wutzler P (2009). Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol 198, 93–101. 10.1007/s00430-009-0108-7. - DOI - PubMed

LinkOut - more resources